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protamine,8 halofuginone,9 and L-minostine10 have been
studied and are shown to inhibit collagen synthesis and
thus to decrease the level of atherosclerosis. Our prelimi-
nary investigations showed that the application of low fre-
quency electrical impulses (EIs) and the subsequent
creation of an electrical field in rabbits with the early stages
of atherosclerosis may inhibit intimal thickening, affect
newly formed atherosclerotic plaque in the endothelium
of vessels, and decrease the extent of previous pathologic
damage in these structures.11,12
After 8 weeks of EIs, the levels of atherosclerosis in the
upper abdominal aorta (AA) at 30 contractions per minute
(cpm) were 0.5 ± 0.1 (3V) versus 2.5 ± 0.4 (2V) and 0.9
± 0.2 (4V). At 60 cpm, the levels were 0.8 ± 0.2 (3V) ver-
sus 2.6 ± 0.5 (2V) and 1.3 ± 0.3 (4V). And at 120 cpm,
the levels were 2.9 ± 0.3 (3V) versus 2.8 ± 0.4 (2V) and
3.2 ± 0.5 (4V) and 2.8 ± 0.5 (control).
Similarly, the combination of 30 cpm and 3V yielded
the best results in terms of percentage of area involved in
the atherosclerosis process. At 30 cpm, these percentages
were 5.2% ± 3.6% (3V) versus 29.3% ± 10.1% (2V) and
17.2% ± 4.3% (4V). At 60 cpm, the percentages were
31.3% ± 7.6% (3V) versus 32.3% ± 2.9% (2V) and 34.7% ±
5.9% (4V). And at 120 cpm, the percentages were 36.0%
± 13.0% (3V) versus 39.3% ± 11.1% (2V) and 30.6% ±
5.7% (4V) and 32.5% ± 15% (control). The best results
were obtained at 3V with a rate of 30 cpm, the combina-
tion we used in the following investigation.
The aim of this study was the determination of the
optimal length of time that EIs should be applied daily to
A large number of diseases are related to atherosclero-
sis and contribute to high rates of morbidity and mortal-
ity.1-3 To manage any complication caused by
atherosclerosis, scientists and researchers are trying to cre-
ate the appropriate conventional treatment method.
Current methods include dilatation of narrowed arteries
with balloon angioplasty or stenting, coronary atherec-
tomy, and bypass grafting of arteries (coronary or periph-
eral). However, some patients are poor candidates for
these treatments because they have severe diffuse disease
with severe ischemia of the target organs or some comor-
bidity. The search continues for a method to inhibit the
development of advanced atherosclerosis.
Theoretically, any treatment of atherosclerosis that
inhibits intimal thickening with the inhibition of collagen
synthesis will reduce the luminal narrowing of the vessel.4
Calcium channel blockers,5 derived dextrans,6 tranilast,7
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Objective: Low frequency electrical impulses (EIs) reduce new atherosclerotic plaque formation in previously diseased
arteries and may reverse the extent of previous pathologic damage in these structures.
Methods: A pacemaker was implanted on the left side of rabbit abdominal aortas, and an electrode was placed close to
the other side of the aorta in the psoas major muscle. For the induction of atherosclerosis, the rabbits were placed on
a high cholesterol diet (HCD) for 11 weeks. No EIs were applied to the control series I. In the experimental series, the
rabbits were fed an HCD for 3 weeks, after which EIs were applied simultaneously with an HCD for 8 additional weeks
(3V, 30 contractions per minute). Experimental series II had 24-hour/day EIs, and series III had 8-hour/day EIs.
Results: The closer to the area where the EIs were applied, the more local severity increased (atherosclerosis level and
surface area). In the control series, the severity of atherosclerosis in the lower aorta assessed with an arbitrary grading
system was 1.75 ± 0.5 (versus 1.5 ± 0.57 with 8-hour/day EIs and 0.5 ± 0.3 with 24-hour/day EIs). The involved
surface area was 32.5% ± 9.5% (versus 1.0% ± 0.8% with 8-hour/day EIs and 0.75% ± 0.95% with 24-hour/day EIs).
Conclusion: Both 24-hour/day and 8-hour/day EIs applied close to the abdominal aorta decreased the severity of ath-
erosclerosis in rabbits placed on a HCD, but 24-hour/day EIs decreased the severity more extensively. (J Vasc Surg
2002;35:554-62.)
obtain the best results. We therefore compared 24-
hour/day EIs and 8-hour/day EIs in a rabbit model of
diet-induced atherosclerosis.
MATERIALS AND METHODS
The animal studies in this investigation were approved
by our institution’s Animal Care Committee, which is in
compliance with all federal laws and with the “Principles
of Laboratory Animal Care” formulated by the National
Society for Medical Research. All the animal studies were
conducted in a full American Association for Accreditation
of Laboratory Animal Care–accredited research facility.
Our investigation used three series of animals: series I
(control, 11 weeks of a high cholesterol diet [HCD] but
no EIs; n = 4 animals), series II (similar diet and with EIs
24hour/day; n = 4 animals), and series III (similar diet
with EIs 8-hour/day; n = 4 animals).
High cholesterol diet
Important similarities between atherosclerosis in a rab-
bit aorta and in a human aorta reinforce the advantages of
this model. In rabbits fed a cholesterol-rich diet, a similar
pattern of plaque distribution, especially in the young,13-
21 to the disease distribution pattern in rabbits and
humans is similar in the aorta but dissimilar in some
peripheral arteries. In adult human arteries, lesions more
frequently form upstream of branch points than they do
downstream.22-24
All the rabbits were put on a 2% cholesterol diet and
fed the same amount of food at the same times. The
plasma cholesterol levels were determined in all animals
with the Abbott VP Blood Chemistry Analyzer (Abbott
Laboratories, Inc, Abbott Park, Ill) at the conclusion of
the experiment.
Operative technique
Animal preparation. Before surgery, the rabbits
underwent anesthesia with a cocktail of ketamine
hydrochloride (25 mg/kg intramuscularly), acepromazine
maleate (1 mg/kg intramuscularly), and glycopyrrolate
(0.22 mg/kg intramuscularly). Once they were sedated,
the rabbits were placed on a semi-open, nonrebreathing
ventilation system with halothane gas (0.75% to 2%)
mixed with 2 to 3 L O2 via mask and then given buprenor-
phine hydrochloride (0.05 mg/kg intramuscularly) for
pain (two thirds of the dose after the induction of anes-
thesia and one third after recovery from surgery).
Additional pain medication was given as needed
(buprenorphine hydrochloride 0.02 to 0.05 mg/kg twice
a day). Antibiotic therapy included enrofloxacin (5 to 10
mg/kg intramuscularly twice a day for 14 days) to treat
pasteurella pneumonia, if necessary, and chloramphenicol
sodium succinate (30 mg/kg intramuscularly once per day
for 5 to 7 days) for prophylactic postoperative treatment
of infection. The incision sites were checked at least once
daily for any abscess formation.
Stimulator and lead implantation. The surgery was
performed with strict sterile technique. After the induc-
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tion of anesthesia, the rabbits had the stimulating lead
implanted into the right psoas major muscle close to the
upper part of the AA. The lead for the myostimulator was
tunneled behind the vertebral column on the left side and
connected to the pacemaker (Terra, Medtronic, Inc,
Minneapolis, Minn), which was implanted in a pocket
between the left psoas major muscle and the abdominal
oblique muscle, close to the upper part of the AA (Fig 1).
The incision was closed in layers with tie sutures. The
same surgery was performed on the animals in all three
series, but EIs were used only in series II and III.
The pacemaker and lead were implanted in such a
manner that electrical current flowing from the pacing
lead to the generator crossed the AA. Pacing impulses of
30 cpm at 3V were programmed with a Medtronic pro-
grammer.
Previous investigations11,12 have shown that early ath-
erosclerosis appears in the AA, the area of particular inter-
est in these studies, within 3 weeks of beginning an HCD.
In pilot studies, atherosclerosis in the coronary arteries
was advanced and many rabbits died with myocardial
infarction after week 11. On the basis of these observa-
tions, the study design was to feed experimental animals
with an HCD for 3 weeks and then apply EIs for an addi-
tional 8 weeks while maintaining this diet, for a total
period of 11 weeks.
Pathology investigations
Evaluation of atherosclerosis. After death, the heart
aortic arch and the entire aorta plus the iliac arteries were
removed. These tissues were fixed in formalin and stained
with Sudan IV dye, and the extent of stainable lipid on the
surface then was assessed. Atherosclerosis was assessed
Fig 1. Drawing shows electrode implanted in psoas major mus-
cle and stimulator lead placed opposite near abdominal aorta.
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with the following arbitrary scale of 1 to 4 in hematoxylin-
stained sections (Fig 2): trace, minimal thickening of the
endothelium; grade 1, plaque containing foam cells less
than half as thick as the media (Fig 2, C); grade 2, plaque
half as thick as the media or more with accumulation of
intracellular lipid (lesions as advanced as this often con-
tained areas of fibrosis, but its presence did not affect
grading; Fig 2, D); grade 3, plaque at least as thick as the
media; and grade 4, plaque thicker than the media with
evidence of cellular degeneration, fibrosis, or both.
For the calculation of the percentage of surface area
involved in the atherosclerotic process, gross examination
was used. The entire aorta was dissected and removed (Fig
3), and then the aorta was divided into the following four
sections: the upper thoracic aorta (from the aortic arch to
the mid point of the thoracic aorta), the lower thoracic
aorta (from the mid point of the thoracic aorta to the level
of the diaphragm), the upper AA (from the level of the
diaphragm to the mid point of the AA), and the lower AA
(from the mid point of the AA to the bifurcation of the
aorta).
Gross color photographs of Sudan-stained sections of
the aorta were overlaid with a transparent grid that con-
tained 100 squares. Because the overlay was larger than
Fig 2. Histopathologic section of aorta. A, Healthy, without atherosclerosis. B, Trace of atherosclerosis. C, Level I atherosclerosis. D,
Level II atherosclerosis. E, Level III atherosclerosis. F, Level IV atherosclerosis. Scale bar represents 25 mm.
A
B
C
D
E
F
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the examined section of the aorta, only the squares on the
overlay that fell within the specimen were counted. Next,
the number of squares that contained aortic lesions was
counted. The number of squares with lesions then was cal-
culated as a percentage of the total number of overlay
squares contained within the specimen. All the micro-
scopic evaluations were done without the evaluator know-
ing the treatment for any of the rabbits.
In a previous study,11,12 we found that a stimulation
regimen of 3V impulses at 30 cpm has the best results in
the reduction of atherosclerosis as compared with other
voltages (2V, 4V) or impulse rates (60 cpm, 20 cpm).
Therefore, we used this regimen in this study. Stimulation
at 3V produced slight muscle contractions but did not dis-
turb the animals.
Statistical analysis
The results are expressed as the mean ± the standard
error of the mean. All the analyses were performed by one
of the authors (MAM) with appropriate software (Statview
5.0, SAS Institute, Inc, Cary, NC). All the continuous
variables (in control and 24-hour and 8-hour EI groups)
were studied with analysis of variance. If a resultant frac-
tion was found to be significant (ie, established at P < .05),
a Scheffé test was used to specify pairwise differences. 
RESULTS
No animals lost weight during the course of the study.
The condition and overall activity level of the electrically
stimulated animals was no different from those in the con-
trol series. 
Upper thoracic aorta (Figs 4 and 5). The grades of
atherosclerosis were higher in the control series (3.0 ± 1.1)
and in the rabbits subjected to 8-hour EIs (3.0 ± 0.8) as
compared with those subjected to 24-hour EIs (1.75 ± 0.9).
The difference between the three series was statistically non-
significant (P > .05). However, in two of the four rabbits
subjected to 24-hour/day EIs, the atherosclerosis level in
the upper thoracic aorta was only 1+. Gross examination
results revealed that the percentage of atherosclerotic surface
was significantly less (P < .05) in the series subjected to 24-
hour/day EIs, but not to 8-hour/day EIs, as compared with
the control series: 67.5 ± 33.04 (control series), 30.0 ±
23.09 (8-hour EIs), and 12.5 ± 11.9 (24-hour EIs).
Lower thoracic aorta (Figs 4 and 5). After 11
weeks of an HCD, the atherosclerosis grades in the lower
Fig 3. Autopsy photographs of thoracic aorta after: A, 11 weeks of high cholesterol diet (HCD) only; B,
11 weeks of HCD plus 24-hour/day electrical impulses; and C, 11 weeks of HCD plus 8-hour/day elec-
trical impulses.
A
B
C
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thoracic aorta were 2.75 ± 0.5 in the control series.
Although the grades were lower in the 8-hour/day EIs
series (2.0 ± 0.8), the difference in the grades was not sta-
tistically significant (P > .05). The grade was lower in the
24-hour/day EIs series (1.25 ± 0.5) than in the control
series and in the 8-hour EIs series, but this difference was
statistically significant (P < .05) only when contrasted with
the control series.
Gross examination results showed that the percentage
of atherosclerotic surface was 47.5% ± 17.0% in the con-
trol series but only 18.0% ± 23.1% in the 8-hour/day EIs
series. Although there was a difference between the con-
trol and 8-hour/day EIs series, this difference was not sta-
tistically significant. The percentage was 2.75% ± 2.6% in
animals in the 24-hour/day EIs series, which was consid-
erably less than in either the control or 8-hour/day EIs
series (P < .001).
Upper abdominal aorta (Figs 4 and 5). The athero-
sclerosis grades in the upper AA were practically the same
as in the lower thoracic aorta (2.75 ± 0.5 in the control
series, 2.0 ± 0.8 in the 8-hour/day EIs series, and 1.25 ±
0.35 in the 24-hour/day EIs series), which was not signif-
icantly less (P > .05) as compared with the 8-hour/day EIs
series but was significantly less (P < .05) as compared with
controls. Gross examination results showed that the differ-
ence in the percentage of involved surface area was statisti-
cally significant (P < .001): 32.5% ± 15.0% (control series)
versus 5.25% ± 3.6% (24-hour/day EIs). Results from the
8-hour/day EIs were between those of the control and 24-
hour/day EIs series: (11.5% ± 8.1%; P > .05 versus control
and 24-hour EIs).
Lower abdominal aorta (Figs 4 to 7). Greater dif-
ferences in atherosclerosis grades were found in the lower
AA (ie, in the area where the pacemaker and electrode
were implanted). The grades were 1.75 ± 0.5 in the con-
trol series versus 0.5 ± 0.3 in the 24-hour/day EI series (P
< .05). In contrast, the atherosclerosis grades in three rab-
bits in the control series were 2+, but in three rabbits in
the 24-hour/day EIs series, there were no signs of athero-
sclerosis (grade 0). Eight hours of EIs daily did not change
the atherosclerosis grades in the lower AA as compared
with the control series (1.5 ± 0.5; P > .05).
Histologic examination results of the control rabbits
revealed that the elastic lamina was distorted and that the
distance between the lumina of the aorta and the elastic
lamina was considerably increased, which caused a moder-
ately fatty plaque. Many fat-laden macrophages were pres-
ent, and their cytoplasm were filled with lipid droplets
(foam cells) as the result of lipid digestion. Throughout
these foam cell–rich areas in the intima, the smooth mus-
cle cells had migrated and proliferated, lipids had accumu-
lated, and there were lipid deposits in the extracellular
matrix. However, in rabbits with 24-hour/day EIs, there
was no endothelial cell injury in the AA. The elastic lam-
ina was undisturbed. In the rabbits with 8-hour/day EIs,
some monocytes had migrated into the subendothelial
layer and occasionally a few fat-laden monocytes were
found between the endothelium and the elastic lamina.
Gross examination results revealed that the percentage
of involved surface area was 32.5% ± 9.5% in the control
series and only 0.75% ± 0.9% in the 24-hour/day EIs
series (P < .001). Initial findings of involved surface area
Fig 4. Graph shows aortic thickness grade in upper thoracic aorta (UTA), lower thoracic aorta (LTA),
upper abdominal aorta (UAA), and lower abdominal aorta (LAA). EI, Electrical impulses.
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Fig 6. Histopathologic section of lower abdominal aorta. A, Level II to III atherosclerosis with high cho-
lesterol diet (HCD) but no electrical impulses (EIs). B, Disease free with HCD plus 24-hour/day EIs. C,
Level I atherosclerosis with HCD plus 8-hour/day EIs.
A B C
Fig 5. Graph shows percentage of involved surface area in upper thoracic aorta (UTA), lower thoracic
aorta (LTA), upper abdominal aorta (UAA), and lower abdominal aorta (LAA). EI, Electrical impulses.
from the 8-hour/day EIs series were similar to those of
the 24-hour/day EIs series (1.0% ± 0.8%; P < .001 versus
control, but P > .05 versus 24-hour EIs). Moreover, in
three of eight rabbits in the two EIs series, the lower AA
had no atherosclerotic areas as compared with 40% of
involved surface area in two rabbits in the control series.
Our data showed that, in both the control group and
the groups subjected to EIs, there was a decrease in
atherosclerotic burden in the more distal aortic regions.
The atherosclerotic level in the lower AA of the control
group was 1.75 ± 0.5 versus 3.0 ± 1.1 in the upper tho-
racic aorta. However, this difference was not statistically
significant (P > .05). In the 24-hour/day EIs group, the
level of atherosclerosis in the lower AA was only 0.5 ± 0.3,
which was significantly less than that of the control group
(1.75 ± 0.5; P < .05) and the upper thoracic aorta of the
electrically stimulated animals (1.75 ± 0.9; P < .05). Thus,
in keeping with the data of many other investigators, there
was centrifugal spread of the process down the aorta.
Serum cholesterol level. After 11 weeks of an HCD,
the serum cholesterol levels in the control animals
increased from 292 ± 81 mg/dL to 1736 ± 158 mg/dL
(P < .001). In the 24-hour/day EIs group, the serum cho-
lesterol levels increased to 1562 ± 114 mg/dL (P < .001
versus baseline, but P > .05 versus control). In the 8-
hour/day EIs group, the serum cholesterol levels were
1786 ± 137 mg/dL (P < .001 versus baseline, but P > .05
versus control and 24-hour/day EIs). 
DISCUSSION
Our interest in EIs for the prevention of atherosclero-
sis came from our initial studies of low frequency EIs in
ischemic muscle, in which we found that the process of
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angiogenesis starts with doubling capillary density in the
target muscle after EIs are applied.25,26 However, no such
effect is possible without the beneficial influence of EIs on
the morphology of the endothelial cells and on vascular
endothelial growth factor (VEGF). It is well known that
VEGF is a prototypic angiogenic growth factor that is
associated with angiogenesis in vivo and causes endothelial
cell proliferation in vitro.27,28 Annex et al29 strongly sup-
ported the hypothesis that some regimen of EI may play a
positive role in severely ischemic tissue, which shows that
chronic motor nerve stimulation increases VEGF at the
protein level. Hang et al30 showed similar findings with
the increase of VEGF protein in hypoxia, especially in con-
junction with EIs.
In our previous investigations, we examined endothe-
lial cells during acute ischemia and when subjected to dif-
ferent regimens of EIs. Most endothelial cells were
damaged when EIs were applied at 60 cpm.25,26 On the
basis of these findings, we hypothesized that low fre-
quency EIs: 1, reduce damage to endothelial cells from
both ischemia and atherosclerosis; 2, prevent new athero-
sclerotic plaque from developing in previously diseased
vessels; and 3, perhaps even reduce the extent of previous
pathologic damage in these structures. Our evaluation of
the atherosclerotic process includes both local severity of
atherosclerosis and the percentage of the surface area
involved in the affected vessel.
We found that the percentage of atherosclerotic sur-
face was lower in all four rabbits in the 8-hour/day series
than in the control series in the lower AA. The level of ath-
erosclerosis was not significantly different from the control
series. When we compared the 8-hour/day EIs series with
the 24-hour/day EIs series, we found that the atheroscle-
rosis levels were less in the 24-hour/day EIs series. This
difference was not statistically significant (P > .05) in the
thoracic aorta, but it was statistically significant (P < .05)
in the lower AA near the area where the EIs were applied.
As noted previously, in general, atherosclerosis tends
to decrease when moving downward from the thoracic
aortic to the AA. The level of atherosclerosis decreased
from 3.0 ± 1.1 (upper thoracic aorta) to 1.75 ± 0.5 (lower
AA) in the control series, from 1.75 ± 0.9 to 0.5 ± 0.3 in
the 24-hour/day EIs series, and from 3.0 ± 0.8 to 1.5 ±
0.5 in the 8-hour/day EIs series.
Our data showed that EIs have a greater influence on
the development of atherosclerosis in the more distal
aorta. The difference was statistically significant, even in
the upper thoracic aorta: 12.5% ± 11.9% (24-hour/day
EIs) versus 67.5% ± 33.0% (control; P < .05). In the lower
AA, the difference was evident: 0.75% ± 0.9% (24-
hour/day EIs) versus 32.5% ± 9.5% (control; P < .001).
The involved surface area in the lower AA with 8-
hour/day EIs was small: only 1.0% ± 0.8% (P < .001) ver-
sus the control series. However, the level of atherosclerosis
with 8-hour/day EIs was close to that in the control
series: 1.5 ± 0.5 versus 1.75 ± 0.5 (P > .05).
Among the interesting results, after 11 weeks of an
HCD, the AA in the control animals had 32.5% ± 9.5% of
Fig 7. Autopsy photographs of abdominal aorta after (upper) 8-
hour/day electrical impulses (EIs), (middle) 24-hour/day EIs,
and (lower) no EIs.
involved surface area and a plaque thickness level of 1.75
± 0.5 (ie, advanced atherosclerosis). When EIs were
applied to the AA for 8 hours/day for 11 weeks, the
involved area diminished from 32.5% to 1%, but the
plaque thickness level (in this case, 1% of the area)
remained the same as in the control animals. These find-
ings changed dramatically when 24-hour/day EIs were
applied; both atherosclerotic surface area (0.75% ± 0.9%
versus 32.5% ± 9.5%) and atherosclerosis level (0.5 ± 0.3
versus 1.75 ± 0.5) considerably decreased as compared
with the control animals. In other words, 8-hour/day EIs
decreased only the involved surface area, whereas 24-
hour/day EIs decreased both surface area involvement
and atherosclerosis level.
All of our experimental data showed that EIs applied
around the aorta can prevent, and even decrease, fatty
deposits, despite a continued HCD, by yet unclear mech-
anisms. The relationship between atherosclerosis and
angiogenesis is now being scrutinized.31 The results are
controversial. Some treatment scenarios favor proangio-
genesis, others favor antiangiogenesis. Moulton et al32
showed that neovascularization in the lesion is proathero-
sclerotic.
Recently, several investigations showed the possibility
of regressing established atherosclerosis in rabbits with
protein-bound polysaccharide,33 with vaccine-induced
antibodies,34 with policosanol,35 with mycophenolate
mofetil,36 and with L-arginine.37 Because the application
of EIs is still a new approach, additional studies are needed
to add EI application to this list and confirm its efficacy.
One possible explanation of the mechanism for the
prevention of atherosclerotic plaque formation may be in
the change in iron ion concentration in the AA with the
influence of EIs. It is now known that redox-active iron
can initiate lipid peroxidation, an important early event in
the development of atherosclerosis.38,39 In an animal
model of atherosclerosis,40 it was shown that the progres-
sion of atherosclerosis and low density lipoprotein oxida-
tion are closely related to vascular iron deposition.
Any method that decreases the availability of iron for
the production of reactive oxygen species41 will be useful
for atherosclerosis prevention.42 Halliwell41 showed that
in higher concentrations (>0.05 mmol/L), deferoxamine,
an iron chelator, may scavenge reactive oxygen species.
Iron is known to stimulate low density lipoprotein and
membrane lipid peroxidation,38,39,43 and its transition
metal ions are present in atherosclerotic lesions in sufficient
quantities to catalyze this reaction.39 Duffy et al42 reported
that non-protein bound iron may directly inactivate nitric
oxide43 and iron may be mobilized from ferritin by super-
oxide,44 which is increased in atherosclerosis.45 Therefore,
if deferoxamine decreases the atherosclerotic lesion with
iron chelation,41,42 low frequency EIs, by creating an elec-
trical field around the target vessels (in this case, the AA),
may also decrease atherosclerotic lesions or even prevent
their development by removing the iron ions from the tar-
get vessels. This is only a preliminary hypothesis because we
did not measure serum iron levels in this study.
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This study did provide evidence that EI application
may prove to be a useful tool for atherosclerosis preven-
tion and treatment in those at risk for, or with, aortic ath-
erosclerosis or peripheral vascular disease. It can be used
regardless of degree of vessel patency or the number of
atherosclerotic vessels, and it does not traumatize the
inner wall of the vessel. EIs may be applied with the
implantation of electrodes intramuscularly, topically, or
intravenously close to target vessels.
CONCLUSION
Our study has yielded new data about the possible
future use of EIs in atherosclerosis prevention and reversal
in rabbits. In a previous investigation, we found that the
best variant of EIs for the prevention of atherosclerosis in
a rabbit aorta was 3V and 30 cpm. This study shows that
continuous EIs (24 hours/day) yield better results than
do 8-hour/day EIs and that the optimal variant now
becomes 24-hour/day EIs at 3V and 30 cpm.
Contemplated further may be attempts to answer the
following questions:
1. Can these results be approximated with EIs (or an
electrical field) in animals and later in patients who have
atherosclerosis of varying severity in other arteries (eg, in
the coronary arteries, the carotid arteries, and the iliac and
femoral arteries, or in the AA)?
2. Can EI application be integrated with other meth-
ods of accelerating angiogenesis in patients who have ath-
erosclerosis included in blood flow and deterioration in
angiogenesis and vasculogenesis?
3. Can we determine the actual mechanism of how EI
application affects the formation of atherosclerosis (ie, the
influence of EIs primarily on contracting muscle, on
smooth muscle cell migration, on the stability of the
endothelial cell layer, or, as we suspect, on the adhesion of
leukocytes and platelets to the endothelium)?
We thank Brian Miller and Brian Schurrer for their
technical assistance in preparing the figures for this manu-
script and Debra Waller, Barbara Danek, and Rob
Henderson for their editorial assistance.
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